Clinical Trial Update: Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients [NA]

View source ↗

Summary

A Kaiser Permanente-sponsored clinical trial evaluating hypoglycemia prevention in high-risk Type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Kaiser Permanente | Conditions: Diabetes | NA | Status: COMPLETED